Aspirin use may increase HF risk | In-hospital mortality among COVID-19 patients with HF | DAPT after PCI

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients. 

No such trend was reported among patients with end-stage kidney disease.

Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

The full analysis was published in Circulation: Heart Failure. 

The Disrupt BTK II study will include 250 patients overall. 

The analysis included outcomes data from nearly 1,500 PCI patients. 

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

That's lower than the 76% mark reported in 2019, which is likely due to restrictions and lockdowns during the pandemic.